Omalizumab updosing allows disease activity control in refractory patients with chronic spontaneous urticaria.

This article is protected by copyright. All rights reserved. PMID: 29368377 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research